We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+31.93%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$254M
AUM Growth
+$2.37M
Cap. Flow
-$21.5M
Cap. Flow %
-8.46%
Top 10 Hldgs %
62.37%
Holding
58
New
30
Increased
6
Reduced
5
Closed
17

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$21.3M
2
LLY icon
Eli Lilly
LLY
+$19.9M
3
CCXI
ChemoCentryx, Inc.
CCXI
+$14.8M
4
ARGX icon
argenx
ARGX
+$14.7M
5
APLS
Apellis Pharmaceuticals
APLS
+$12.5M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$28.6M
2
BAX icon
Baxter International
BAX
+$25.1M
3
WBA
Walgreens Boots Alliance
WBA
+$14.7M
4
MRK icon
Merck
MRK
+$13.7M
5
MDT icon
Medtronic
MDT
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 87.13%
2 Consumer Staples 4.82%
3 Financials 0%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.72B
– –
-135,055
Closed -$12.5M
TBPH icon
52
Theravance Biopharma
TBPH
$875M
– –
-129,192
Closed -$956K
WBA
53
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-350,000
Closed -$16.5M
WBA
54
DELISTED
Walgreens Boots Alliance
WBA
– –
-312,847
Closed -$14.7M
EGRX
55
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-122,503
Closed -$6.83M
ISEE
56
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-377,708
Closed -$6.13M
CCXI
57
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-276,400
Closed -$4.73M
HZNP
58
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-261,500
Closed -$28.6M
1 2
3

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Tri Locum Partners held 58 positions worth $254M, up 0.94% from $252M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Tri Locum Partners withdrew a net $21.5M in Q4 2021, closing 17 positions and reducing 5 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 76% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Tri Locum Partners opened a new position in AbbVie worth $24.4M.

  • Tri Locum Partners's largest Q4 2021 buy was AbbVie: 179,950 shares worth $24.4M.
  • Tri Locum Partners added most to ChemoCentryx, Inc. in Q4 2021, an estimated $14.8M increase.
  • Tri Locum Partners's biggest Q4 2021 reduction was Xenon Pharmaceuticals, cutting an estimated $7.14M.
  • Tri Locum Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, selling an estimated $28.6M.
  • Tri Locum Partners's ten largest holdings make up 62% of its $254M portfolio in Q4 2021.
  • Tri Locum Partners opened 30 new positions and closed 17 in Q4 2021.
  • Tri Locum Partners's portfolio value rose 0.94% quarter-over-quarter to $254M.

Based on Tri Locum Partners's 13F filing for Q4 2021, filed 14 Feb 2022.